NewsnReleases

Financial news, corporate announcements, analysts’ reports

All posts tagged AbbVie Inc.

AbbVie to buy ImmunoGen for $10.1 billion, boosting its oncology portfolio

Posted on Author NNRPosted in WireLeave a Reply

AbbVie Inc. (NYSE: ABBV) announced today that it has agreed to acquire ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company focused on developing antibody-drug conjugates (ADCs) for the treatment of cancer. The deal values ImmunoGen at $31.26 per share in cash, or about $10.1 billion in total. The acquisition will give AbbVie access to ImmunoGen’s flagship…

Read

AbbVie Inc.

Posted on Author NNRPosted in Companies listed on New York Stock ExchangeLeave a Reply

AbbVie Inc. is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. Traded as:           NYSE: ABBV;       S&P 100 component;      S&P 500 component Industry:              Biopharmaceutical Founded:            2013; 7 years ago Headquarters:   Lake Bluff, Illinois, United States Products:             Pharmaceutical drugs Website:              www.abbvie.com